Myoglobin Market Size

Myoglobin Market size was over USD 102.76 billion in 2024 and is poised to exceed USD 173.25 billion by 2037, witnessing over 4.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of myoglobin is evaluated at USD 106.34 billion.
 

The growth of the market is primarily attributed to the myoglobin utility as a highly accurate biomarker. For instance, it was observed in research that myoglobin outperforms other cardiac-specific biomarkers in COVID-19 diagnosis. Additionally, the increasing knowledge of myoglobin's effectiveness as a reliable indicator of left ventricular wall thickening which is also known as left ventricular hypertrophy (LVH), is driving the growth of the market in the forecast period. For instance, left ventricular hypertrophy (LVH) affects around 17% to 20% of the population. It is commonly found in blacks, the elderly, the obese, and hypertension patients.

Myoglobin is a tiny heme globular protein that primarily exists in the skeletal and cardiac muscles of mammals. It is an oxygen-binding molecule. The protein's primary job is to store and supply oxygen to muscles that are working hard when blood oxygen delivery is partially inadequate. When cells get damaged, these proteins get released into the blood. It is found in many diving mammals, i.e., whales and seals, and allows them to remain submerged for a longer period of time. As an oxygen binding blood cell proteins, myoglobin and hemoglobin have very similar chemical structure owing to the existence of a molecule called heme, which is primarily responsible for allowing oxygen binding with hemoglobin and myoglobin.